Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Amortization of Deferred Charges (2021)

Verrica Pharmaceuticals (VRCA) has 1 years of Amortization of Deferred Charges data on record, last reported at $58000.0 in Q4 2021.

  • For Q4 2021, Amortization of Deferred Charges changed N/A year-over-year to $58000.0; the TTM value through Dec 2021 reached $228000.0, changed N/A, while the annual FY2021 figure was $228000.0, 22.58% up from the prior year.
  • Amortization of Deferred Charges reached $58000.0 in Q4 2021 per VRCA's latest filing, up from $57000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $58000.0 in Q4 2021 and bottomed at $56000.0 in Q1 2021.